First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+ cancers Meeting Abstract
| Authors: | Ho, A. L.; Posner, M. R.; Niu, J.; Fu, S.; Leidner, R. S.; Pearson, A. T.; Chung, K. Y.; Richardson, D. L.; Wang, D.; Pimentel, A.; Nieva, J. J.; Rosenberg, A.; Burman, B.; Iacobucci, C.; Qing, X.; Hwang, A.; Katchar, K.; Schlienger, K.; Matushansky, I.; Pfister, D. G. |
| Abstract Title: | First report of the safety/tolerability and preliminary antitumor activity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with HPV16+ cancers |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120601024 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.2502 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2502 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work